CROI 2019 Abstract eBook

Abstract eBook

General Information

ABSTRACT PROCESS

General Information

Scientific Categories A. Virology B. Pathogenesis: Human Studies and Animal Models C. HIV-Associated Tumor Viruses D. Host Immune Responses to Infection, Vaccines, and Immunotherapy E. HIV Reservoirs, Latency, and All Curative Strategies Including Therapeutic Vaccines and Gene Therapy F. Neuropathogenesis and Neurologic Complications G. Clinical Pharmacology H. Antiretroviral Therapy: Pre-Clinical Data, Randomized Trials, Efficacy and Effectiveness Studies I. HIV Drug Resistance J. HIV Diagnostics K. Hepatitis Viruses and Liver Complications L. AIDS-Related Malignancies M. Cardiovascular Complications of HIV Infection and Antiretroviral Therapy N. Other Complications of HIV Infection and Antiretroviral Therapy O. Tuberculosis and Other Opportunistic Infections P. Maternal and Fetal HIV Q. Pediatrics and Adolescents R. Epidemiology S. Testing T. Prevention Interventions U. Contraception, Sexually Transmitted Infections, and Reproductive Health V. Implementation and Scale-Up of Treatment and Care W. Population and Cost Modeling Abstract Content Author names, institutions, titles, and abstracts in the Abstract eBook and other materials are gernerally presented as submitted by the corresponding author. Abstract Review Process The PC and a panel of volunteer external reviewers reviewed more than 2000 submitted abstracts. Each abstract was reviewed by 5 to 10 reviewers selected for each abstract category based upon their individual expertise. PC members and external experts in the field reviewed the abstracts for the quality and originality of the work and scored them numerically. All reviewers were instructed to abstain from scoring any abstract on which they are an author or coauthor, have a financial or personal conflict of interest, or do not have the appropriate expertise to evaluate. Scores ranged from 1 (definite oral presentation) to 5 (rejected). Scores for each abstract were averaged and the standard deviation was calculated to assess variability. If variability was high, outlier scores were identified and censored. Abstracts with high variability in scores were discussed individually during a series of conference calls for each scientific category. Abstracts were accepted for oral presentations, for poster presentations, or rejected. Late-breaking abstract reviews included an assessment of the late-breaking nature of the work (distinct from a late submission).

2

CROI 2019